BRCA1 and ovarian cancer: The cumulative risk of breast and ovarian cancer for females with the BRCA1/2 gene PV or LPV increases with age, specifically with an estimated penetrance of 60–70% and 20–30% for breast and ovarian cancer, respectively, by the age of 704–6.